Too Soon To Declare Whether Immunotherapy Can Cure Metastatic RCC – Cancer Therapy Advisor
|
Too Soon To Declare Whether Immunotherapy Can Cure Metastatic RCC
Cancer Therapy Advisor The treatment of metastatic renal cell carcinoma (mRCC) has undergone several major changes, with the first approval of targeted therapy in 2005 and the first approval of an immune checkpoint inhibitor in 2015. The success of targeted therapy is … |
